Variable (%, 95Â % CI) | Used amoxicillin (NÂ =Â 60) | Responders not using amoxicillin at follow-up (NÂ =Â 190) | Non responders (NÂ =Â 116) | Reacted to subsequent dose (NÂ =Â 7) |
---|---|---|---|---|
Sex (males %) | (29 of 60) 48.3 (35.4, 61.5) | (101 of 190) 53.2 (45.8, 60.4) | (67 of 116) 57.8 (48.2, 66.8) | (4 of 7) 57.1 (20.2, 88.2) |
Age at reaction (median, IQRÂ =Â Interquartile range) | 1.0 (0.4, 2.0) | 1.2 (0.5, 3.0) | 1.0 (0.5, 2) | 0.9 (0.5, 3.9) |
Age at challenge (IQR) | 2.6 (1.6, 4.6) | 4.2 (2.0, 7.9) | 3.5 (2.1, 5.5) | 2.1 (1.8, 5.3) |
Time interval years between reaction and challenge (median, IQR) | 1.1 (0.5, 2.1) | 1.8 (1.0, 4.9) | 1.7 (0.9, 3.3) | 1.3 (0.8, 1.6) |
Amoxicillin given for AOM (acute otitis media) | 73.3 (60.1, 83.5) | 66.3 (59.0, 72.9) | 64.3 (54.8, 72.9) | 42.9 (11.8, 79.8) |
Characteristics of initial reaction | ||||
 Hives | 75.0 (61.9, 84.9) | 56.8 (49.5, 63.9) | 62.9 (53.4, 71.6) | 100 % (56.1, 100.0 %) |
 Macular/papular rash | 16.7 (8.7, 29.0) | 34.2 (27.6, 41.5) | 31.0 (23.0, 40.4) |  |
Between 1–3 days | 51.7 (38.5, 64.6) | 52.1 (44.8, 59.4) | 44.7 (35.5, 54.3) | 28.6 (5.1, 69.7) |
Between 4–7 days | 20.0 (11.2, 32.7) | 26.1 (20.1, 33.1) | 33.3 (25.0, 42.9) | 28.6 (5.1, 69.7) |
>7Â days | 21.6 (12.5, 34.5) | 14.7 (9.8, 20.4) | 15.8 (9.9, 24.1) | 28.6 (5.1, 69.7) |
After treatment ended | 3.3 (0.6, 12.5) | 4.8 (2.4, 9.2) | 2.6 (0.6, 8.1) | 14.3 (0.7, 0.6) |
Known asthma | 8.5 (3.2, 19.4) | 15.9 (11.1, 22.0) | 16.8 (10.7, 25.3) | 14.3 (0.7, 0.6) |
Known eczema | 23.7 (14.0, 36.9) | 21.2 (15.7, 27.8) | 23.0 (15.8, 32.1) | 28.6 (5.1, 69.7) |
Parental history of drug allergy | 43.2 (27.5, 60.4) | 26.5 (19.4, 35.0) | 29.3 (20.0, 40.5) | 50.0 (18.8, 81.2) |
Parental history of asthma | 29.3 (12.4, 41.6) | 15.9 (10.3, 23.5) | 9.8 (4.6, 18.8) | 0 |